Psoriasis and Atherosclerotic CV Disease-Risk Factor or Risk Marker?
作者信息
Garshick Michael S, Weber Brittany N, Gelfand Joel M
机构信息
Center for the Prevention of Cardiovascular Disease and the Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York.
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York.
出版信息
JAMA Cardiol. 2024 Nov 1;9(11):961-963. doi: 10.1001/jamacardio.2024.2868.
Abstract
摘要
相似文献
1
Psoriasis and Atherosclerotic CV Disease-Risk Factor or Risk Marker?
JAMA Cardiol. 2024 Nov 1;9(11):961-963. doi: 10.1001/jamacardio.2024.2868.
2
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
Ther Adv Musculoskelet Dis. 2023 Feb 7;15:1759720X221149965. doi: 10.1177/1759720X221149965. eCollection 2023.
3
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
J Eur Acad Dermatol Venereol. 2013 Aug;27 Suppl 3:12-29. doi: 10.1111/jdv.12163.
4
Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients.
Semin Arthritis Rheum. 2023 Jun;60:152198. doi: 10.1016/j.semarthrit.2023.152198. Epub 2023 Mar 29.
5
Cardiovascular Involvement in Psoriasis, Diagnosing Subclinical Atherosclerosis, Effects of Biological and Non-Biological Therapy: A Literature Review.
Cureus. 2020 Oct 26;12(10):e11173. doi: 10.7759/cureus.11173.
6
Management of cardiovascular disease in patients with psoriasis.
Expert Opin Pharmacother. 2016 Aug;17(11):1509-16. doi: 10.1080/14656566.2016.1190336. Epub 2016 May 31.
7
The Oxidative Stress-Induced miR-200c Is Upregulated in Psoriasis and Correlates with Disease Severity and Determinants of Cardiovascular Risk.
Oxid Med Cell Longev. 2019 Dec 19;2019:8061901. doi: 10.1155/2019/8061901. eCollection 2019.
8
Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris.
Exp Dermatol. 2022 Sep;31(9):1341-1351. doi: 10.1111/exd.14582. Epub 2022 May 16.
9
The prevalence of cardiovascular diseases risk factors associated with psoriasis in Saudi Arabia.
Electron Physician. 2017 Nov 25;9(11):5793-5799. doi: 10.19082/5793. eCollection 2017 Nov.
10
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.
Eur Heart J. 2010 Apr;31(8):1000-6. doi: 10.1093/eurheartj/ehp567. Epub 2009 Dec 27.
引用本文的文献
1
Interleukin-17 Inhibitors and Early Major Adverse Cardiovascular Events.
JAMA Dermatol. 2025 Sep 3. doi: 10.1001/jamadermatol.2025.2972.
2
Cardiovascular disease risk in psoriatic disease: mechanisms and implications for clinical practice.
Curr Opin Rheumatol. 2025 Jul 1;37(4):261-268. doi: 10.1097/BOR.0000000000001092. Epub 2025 May 13.
3
Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial.
Circulation. 2025 May 20;151(20):1467-1476. doi: 10.1161/CIRCULATIONAHA.124.072756. Epub 2025 Apr 21.
本文引用的文献
1
Exploring the Link Between Genetic Predictors of Cardiovascular Disease and Psoriasis.
JAMA Cardiol. 2024 Nov 1;9(11):1009-1017. doi: 10.1001/jamacardio.2024.2859.
2
Characterization of cardiometabolic risk awareness among patients with psoriasis: A quality improvement survey study.
JAAD Int. 2024 Apr 6;16:72-74. doi: 10.1016/j.jdin.2024.03.020. eCollection 2024 Sep.
3
Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis.
Dermatol Clin. 2024 Jul;42(3):417-428. doi: 10.1016/j.det.2024.02.008. Epub 2024 Feb 26.
4
Elevated plasma triglycerides increase the risk of psoriasis: a cohort and Mendelian randomization study.
Br J Dermatol. 2024 Jul 16;191(2):209-215. doi: 10.1093/bjd/ljae089.
5
A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study.
J Invest Dermatol. 2024 Jun;144(6):1405-1409.e1. doi: 10.1016/j.jid.2023.12.008. Epub 2024 Jan 4.
6
Associations of polysocial risk score, lifestyle and genetic factors with incident psoriasis: a larger-scale prospective cohort study.
Public Health. 2023 Dec;225:320-326. doi: 10.1016/j.puhe.2023.10.034. Epub 2023 Nov 14.
7
Sore, Hot, and at Risk: The Emerging Specialty of Cardio-Rheumatology.
J Am Heart Assoc. 2023 Jun 6;12(11):e027846. doi: 10.1161/JAHA.122.027846. Epub 2023 May 26.
8
Association of Lipid-Lowering Drugs With Risk of Psoriasis: A Mendelian Randomization Study.
JAMA Dermatol. 2023 Mar 1;159(3):275-280. doi: 10.1001/jamadermatol.2022.6051.
9
Shared genetic risk factors and causal association between psoriasis and coronary artery disease.
Nat Commun. 2022 Nov 2;13(1):6565. doi: 10.1038/s41467-022-34323-4.
10
Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis.
BMC Med. 2022 Nov 1;20(1):421. doi: 10.1186/s12916-022-02617-5.
Zotero 插件